Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

Background and Objectives The aim of this study was to examine the cost‐effectiveness of adding nucleic acid testing (NAT) to serological (antibody and antigen) screening protocols for donated blood in the United States (US) with the purpose of reducing the risks of transfusion‐transmission of hepa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vox sanguinis 2004-01, Vol.86 (1), p.28-40
Hauptverfasser:	Marshall, D. A., Kleinman, S. H., Wong, J. B., AuBuchon, J. P., Grima, D. T., Kulin, N. A., Weinstein, M. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Donors blood screening Cost-Benefit Analysis cost-effectiveness analysis decision analysis model hepatitis B Hepatitis B - diagnosis Hepatitis B - economics Hepatitis B - transmission hepatitis C Hepatitis C - diagnosis Hepatitis C - economics Hepatitis C - transmission HIV Infections - diagnosis HIV Infections - economics HIV Infections - transmission human immunodeficiency virus Humans Mass Screening - economics Mass Screening - methods Models, Economic Nucleic Acid Amplification Techniques - economics United States Virus Diseases - diagnosis Virus Diseases - economics Virus Diseases - transmission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!